MSH|^~\&|PTH|SMH|||201911281318||ORU^R01|4116631|D|2.3|||AL|NE PID|1||SM00041940|LM4541|TEST^ADM^MATILDA||19820507|F||||||||||SM001657/18|9876479911 PV1|1|O OBR|1|22044|00016632^19RS-1^PTH^19RS-1^22044||||201902041000||||||MFM|201902051108|S^SURGICAL SPECIMEN^SURGICAL|||||19RS-1||201911281318|||SOUT OBX|1|TX|Pathology Lab: Royal Columbian Hospital OBX|2|TX|Phone: (604)520-4352 Fax: (604)520-4409 OBX|3|TX| OBX|4|TX|Specimen Number: 19RS-1 OBX|5|TX| OBX|6|TX| OBX|7|TX|ADDENDUM OBX|8|TX| OBX|9|TX|testing OBX|10|TX| OBX|11|TX| ____________________________________ OBX|12|TX| Eileen Szeto OBX|13|TX| Electronically signed: 28/Nov/2019 OBX|14|TX| OBX|15|TX| OBX|16|TX|DIAGNOSES OBX|17|TX|TESTING BIZTALK 2013 OBX|18|TX| OBX|19|TX|SYNOPTIC REPORT OBX|20|TX|-------- Anus - Abdominoperineal Resection, 1 -------- OBX|21|TX| OBX|22|TX|SPECIMEN COMMENT OBX|23|TX| Pertains To: test OBX|24|TX| OBX|25|TX|SPECIMEN OBX|26|TX| Procedure: Abdominoperineal resection OBX|27|TX| OBX|28|TX|TUMOUR OBX|29|TX| Tumour Site: Perianal region OBX|30|TX| Tumour Size: 4 x 3 Centimeters (cm) OBX|31|TX| Histologic Type: Adenocarcinoma OBX|32|TX| Histologic Grade: G3: Poorly differentiated OBX|33|TX| Tumour Extension: Tumour directly invades adjacent structures OBX|34|TX| - test OBX|35|TX| OBX|36|TX|MARGINS OBX|37|TX| All margins are negtive for invasive OBX|38|TX| carcinoma and high-grade intraepithelial OBX|39|TX| neoplasia OBX|40|TX| Margins Examined: Proximal OBX|41|TX| OBX|42|TX|LYMPH NODES, REGIONAL OBX|43|TX| No lymph nodes present OBX|44|TX| OBX|45|TX|TREATMENT EFFECT OBX|46|TX| No known presurgical therapy OBX|47|TX| OBX|48|TX|PATHOLOGIC STAGE OBX|49|TX| pT4 pNX OBX|50|TX| OBX|51|TX|ANCILLARY STUDIES OBX|52|TX| Best Tumour Block(s): test OBX|53|TX| OBX|54|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|55|TX|---------- End of Synoptic Report ---------- OBX|56|TX|-------- Anus - Abdominoperineal Resection, 2 -------- OBX|57|TX| OBX|58|TX|SPECIMEN COMMENT OBX|59|TX| Pertains To: TESTING V.7.0.0.5 OBX|60|TX| OBX|61|TX|SPECIMEN OBX|62|TX| Procedure: Abdominoperineal resection OBX|63|TX| OBX|64|TX|TUMOUR OBX|65|TX| Tumour Site: Perianal region OBX|66|TX| Tumour Size: 5.0 Centimeters (cm) OBX|67|TX| Histologic Type: Adenocarcinoma OBX|68|TX| Histologic Grade: G3: Poorly differentiated OBX|69|TX| Tumour Extension: Tumour directly invades adjacent structures OBX|70|TX| - test test test OBX|71|TX| OBX|72|TX|MARGINS OBX|73|TX| All margins are negative for invasive OBX|74|TX| carcinoma and high-grade intraepithelial OBX|75|TX| neoplasia OBX|76|TX| Margins Examined: Distal OBX|77|TX| OBX|78|TX|LYMPH NODES, REGIONAL OBX|79|TX| No lymph nodes present OBX|80|TX| OBX|81|TX|TREATMENT EFFECT OBX|82|TX| Extensive residual cancer with no evident OBX|83|TX| tumour regression (poor or no response, OBX|84|TX| score 3) OBX|85|TX| OBX|86|TX|PATHOLOGIC STAGE OBX|87|TX| ypT4 pNX OBX|88|TX| OBX|89|TX|ANCILLARY STUDIES OBX|90|TX| Best Tumour Block(s): test OBX|91|TX| OBX|92|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|93|TX|---------- End of Synoptic Report ---------- OBX|94|TX|-------- Breast Invasive Carcinoma, 3 -------- OBX|95|TX| OBX|96|TX|SPECIMEN COMMENT OBX|97|TX| Pertains To: testing v.7.0.0.27 OBX|98|TX| OBX|99|TX|SPECIMEN OBX|100|TX| Skin, Nipple, and Breast; Total mastectomy; OBX|101|TX| Left OBX|102|TX| OBX|103|TX|TUMOUR OBX|104|TX| Invasive Carcinoma: Present OBX|105|TX| Histologic Type: Invasive carcinoma of no special type OBX|106|TX| (ductal, not otherwise specified) OBX|107|TX| Histologic Grade (Nottingham OBX|108|TX| Histologic Score) OBX|109|TX| Glandular (Acinar) / Tubular OBX|110|TX| Differentiation: Score 3 OBX|111|TX| Nuclear Pleomorphism: Score 3 OBX|112|TX| Mitotic Rate: Score 2 OBX|113|TX| Overall Nottingham Score: Grade 3 OBX|114|TX| Tumour Size: 3 Millimeters (mm) OBX|115|TX| Tumour Focality: Single focus of invasive carcinoma OBX|116|TX| Lymphovascular Invasion: Present OBX|117|TX| Skin Invasion: Skin is uninvolved OBX|118|TX| Skin Satellite Foci: Satellite foci not identified OBX|119|TX| Nipple DCIS: DCIS does not involve the nipple epidermis OBX|120|TX| In Situ Component: Not identified OBX|121|TX| OBX|122|TX|MARGINS OBX|123|TX| Invasive Carcinoma Margins: Negative for invasive carcinoma OBX|124|TX| Distance from Closest Margin: Greater than: 4 Millimeters (mm) OBX|125|TX| Closest Margin: Medial OBX|126|TX| DCIS Margins: No DCIS present in specimen OBX|127|TX| OBX|128|TX|LYMPH NODES, REGIONAL OBX|129|TX| No lymph nodes present OBX|130|TX| OBX|131|TX|TREATMENT EFFECT OBX|132|TX| Treatment information not provided OBX|133|TX| OBX|134|TX|PATHOLOGIC STAGE OBX|135|TX| pT1a pNX OBX|136|TX| OBX|137|TX|ANCILLARY STUDIES OBX|138|TX| Best Tumour Block(s): test OBX|139|TX| Block Tested: test OBX|140|TX| Results OBX|141|TX| ER: Negative (Intensity: Negative, 0%), Allred OBX|142|TX| Score: 0/8 OBX|143|TX| Controls OBX|144|TX| ER Internal Positive Control: Present OBX|145|TX| OBX|146|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC February 2019 OBX|147|TX|---------- End of Synoptic Report ---------- OBX|148|TX|-------- Breast Invasive Carcinoma, 4 -------- OBX|149|TX| OBX|150|TX|SPECIMEN COMMENT OBX|151|TX| Pertains To: testing v.7.0.0.28 OBX|152|TX| OBX|153|TX|SPECIMEN OBX|154|TX| Breast; Total mastectomy; Left OBX|155|TX| OBX|156|TX|TUMOUR OBX|157|TX| Invasive Carcinoma: Present OBX|158|TX| Histologic Type: Invasive carcinoma with lobular features OBX|159|TX| Histologic Grade (Nottingham OBX|160|TX| Histologic Score) OBX|161|TX| Glandular (Acinar) / Tubular OBX|162|TX| Differentiation: Score 2 OBX|163|TX| Nuclear Pleomorphism: Score 2 OBX|164|TX| Mitotic Rate: Score 3 OBX|165|TX| Overall Nottingham Score: Grade 2 OBX|166|TX| Tumour Size: Microinvasion only (<= 1 mm) OBX|167|TX| Tumour Focality: Single focus of invasive carcinoma OBX|168|TX| Lymphovascular Invasion: Present OBX|169|TX| In Situ Component: Not identified OBX|170|TX| OBX|171|TX|MARGINS OBX|172|TX| Invasive Carcinoma Margins: Cannot be assessed OBX|173|TX| DCIS Margins: No DCIS present in specimen OBX|174|TX| OBX|175|TX|LYMPH NODES, REGIONAL OBX|176|TX| No lymph nodes present OBX|177|TX| OBX|178|TX|TREATMENT EFFECT OBX|179|TX| Presurgical therapy OBX|180|TX| In the Breast: No residual invasive carcinoma is present in OBX|181|TX| the breast after presurgical therapy OBX|182|TX| OBX|183|TX|PATHOLOGIC STAGE OBX|184|TX| pT1mi pNX OBX|185|TX| OBX|186|TX|ANCILLARY STUDIES OBX|187|TX| Best Tumour Block(s): test OBX|188|TX| Biomarker Testing/Results: Not performed: test OBX|189|TX| OBX|190|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC February 2019 OBX|191|TX|---------- End of Synoptic Report ---------- OBX|192|TX|-------- Breast DCIS, 5 -------- OBX|193|TX| OBX|194|TX|SPECIMEN COMMENT OBX|195|TX| Pertains To: testing v.7.0.0.13 OBX|196|TX| OBX|197|TX|SPECIMEN OBX|198|TX| Procedure: Excision (less than total mastectomy) OBX|199|TX| Specimen Laterality: Right OBX|200|TX| OBX|201|TX|TUMOUR OBX|202|TX| Estimated Size (extent) of DCIS: test OBX|203|TX| Histologic Type: Ductal carcinoma in situ OBX|204|TX| Nuclear Grade: Grade I (low) OBX|205|TX| Necrosis: Present, focal (small foci or single cell OBX|206|TX| necrosis) OBX|207|TX| OBX|208|TX|MARGINS OBX|209|TX| Cannot be assessed - test OBX|210|TX| OBX|211|TX|LYMPH NODES, REGIONAL OBX|212|TX| No lymph nodes present OBX|213|TX| OBX|214|TX|PATHOLOGIC STAGE OBX|215|TX| pTis (DCIS) pN0 OBX|216|TX| OBX|217|TX|ANCILLARY STUDIES OBX|218|TX| Best Tumour Block(s): testing OBX|219|TX| Biomarker Testing/Results: Submitted, see separate report: test OBX|220|TX| OBX|221|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC February 2019 OBX|222|TX|---------- End of Synoptic Report ---------- OBX|223|TX|-------- Endometrium - Hysterectomy, 6 -------- OBX|224|TX| OBX|225|TX|SPECIMEN COMMENT OBX|226|TX| Pertains To: testing v.7.0.0.14 OBX|227|TX| OBX|228|TX|SPECIMEN OBX|229|TX| Procedure: Radical hysterectomy OBX|230|TX| OBX|231|TX|TUMOUR OBX|232|TX| Histologic Type: Endometrioid carcinoma, NOS OBX|233|TX| Histologic Grade: FIGO grade 2 OBX|234|TX| Tumour Size: 3 Centimeters (cm) OBX|235|TX| Myometrial Invasion: Not identified OBX|236|TX| Cervical Stromal Invasion: Present OBX|237|TX| Other Tissue Involvement / Organ OBX|238|TX| Involvement: Left ovary OBX|239|TX| Lymph Vascular Invasion: Focal (2 or fewer) OBX|240|TX| OBX|241|TX|MARGINS OBX|242|TX| Parametrial / Paracervical Margin: Positive for carcinoma OBX|243|TX| OBX|244|TX|LYMPH NODES, REGIONAL OBX|245|TX| No lymph nodes present OBX|246|TX| OBX|247|TX|PATHOLOGIC STAGE OBX|248|TX| pT3a pNX pM1 OBX|249|TX| pM Site(s): Lung OBX|250|TX| OBX|251|TX|ANCILLARY STUDIES OBX|252|TX| Best Tumour Block(s): testing OBX|253|TX| Biomarker Testing: Performed previously: test OBX|254|TX| OBX|255|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|256|TX|---------- End of Synoptic Report ---------- OBX|257|TX|-------- GIST - Biopsy, 7 -------- OBX|258|TX| OBX|259|TX|SPECIMEN COMMENT OBX|260|TX| Pertains To: testing v.7.0.0.7 OBX|261|TX| OBX|262|TX|SPECIMEN OBX|263|TX| Procedure: Endoscopic biopsy OBX|264|TX| OBX|265|TX|TUMOUR OBX|266|TX| Tumour Site: Small Intestine OBX|267|TX| Histologic Type: GIST, epithelioid type OBX|268|TX| Histologic Grade: G2: High grade; mitotic rate > 5 / 5 mm2 OBX|269|TX| Risk Assessment: High risk OBX|270|TX| OBX|271|TX|TREATMENT EFFECT OBX|272|TX| Present OBX|273|TX| OBX|274|TX|ANCILLARY STUDIES OBX|275|TX| Best Tumour Block(s): test OBX|276|TX| Biomarker Testing / Results: Performed, addendum to follow: test OBX|277|TX| OBX|278|TX| OBX|279|TX| OBX|280|TX| Risk Assessment reference: 1 Miettinen M, OBX|281|TX| Lasota J. Gastrointestinal stromal tumors: OBX|282|TX| pathology and prognosis at different sites. OBX|283|TX| Semin Diagn Pathol. 2006;23(2):70-83. OBX|284|TX| OBX|285|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|286|TX|---------- End of Synoptic Report ---------- OBX|287|TX|-------- Lung - Resection, 8 -------- OBX|288|TX| OBX|289|TX|SPECIMEN COMMENT OBX|290|TX| Pertains To: testing v.7.0.0.13 OBX|291|TX| OBX|292|TX|SPECIMEN OBX|293|TX| Procedure: Wedge resection OBX|294|TX| Specimen Laterality: Left OBX|295|TX| OBX|296|TX|TUMOUR OBX|297|TX| Tumour Site: Lower lobe OBX|298|TX| Tumour Focality: Separate tumour nodules of same OBX|299|TX| histopathologic type (intrapulmonary OBX|300|TX| metastases) in same lobe OBX|301|TX| Tumour Size: 4 Centimeters (cm) OBX|302|TX| Histologic Type: Minimally invasive adenocarcinoma, OBX|303|TX| nonmucinous OBX|304|TX| Visceral Pleura Invasion: Present OBX|305|TX| Direct Invasion of Adjacent OBX|306|TX| Structures: Adjacent structures present but not involved OBX|307|TX| Lymphovascular Invasion: Present OBX|308|TX| OBX|309|TX|MARGINS OBX|310|TX| All margins are negative for carcinoma OBX|311|TX| Margins Examined: Bronchial, Vascular, Parenchymal OBX|312|TX| OBX|313|TX|LYMPH NODES, REGIONAL OBX|314|TX| No lymph nodes present OBX|315|TX| OBX|316|TX|TREATMENT EFFECT OBX|317|TX| No known presurgical therapy OBX|318|TX| OBX|319|TX|PATHOLOGIC STAGE OBX|320|TX| pT3 pNX OBX|321|TX| OBX|322|TX|ANCILLARY STUDIES OBX|323|TX| Best Tumour Block(s): test OBX|324|TX| Biomarker Testing/Results: Performed, see separate report: test OBX|325|TX| OBX|326|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|327|TX|---------- End of Synoptic Report ---------- OBX|328|TX|-------- Stomach, 9 -------- OBX|329|TX| OBX|330|TX|SPECIMEN COMMENT OBX|331|TX| Pertains To: testing v.7.0.0.5 OBX|332|TX| OBX|333|TX|SPECIMEN OBX|334|TX| Procedure: Total gastrectomy OBX|335|TX| OBX|336|TX|TUMOUR OBX|337|TX| Tumour Site: Fundus OBX|338|TX| Tumour Size: 4 Centimeters (cm) OBX|339|TX| Histologic Type: Large cell neuroendocrine carcinoma OBX|340|TX| Histologic Grade: G3: Poorly differentiated, undifferentiated OBX|341|TX| Tumour Extension: Tumour invades the submucosa OBX|342|TX| Lymphovascular Invasion: Present OBX|343|TX| OBX|344|TX|TREATMENT EFFECT OBX|345|TX| Residual cancer with evident tumour OBX|346|TX| regression, but more than single cells or OBX|347|TX| rare small groups of cancer cells (partial OBX|348|TX| response, score 2) OBX|349|TX| OBX|350|TX|MARGINS OBX|351|TX| Proximal Margin: Negative for invasive carcinoma OBX|352|TX| Status of Dysplasia at Proximal Positive for carcinoma in situ (high-grade OBX|353|TX| Margin: dysplasia) OBX|354|TX| Distal Margin: Negative for invasive carcinoma OBX|355|TX| Status of Dysplasia at Distal Positive for carcinoma in situ (high-grade OBX|356|TX| Margin: dysplasia) OBX|357|TX| Omental (Radial) Margins: Negative for invasive carcinoma OBX|358|TX| OBX|359|TX|LYMPH NODES, REGIONAL OBX|360|TX| No lymph nodes present OBX|361|TX| OBX|362|TX|PATHOLOGIC STAGE OBX|363|TX| pT1b pNX OBX|364|TX| OBX|365|TX|ANCILLARY STUDIES OBX|366|TX| Best Tumour Block(s): test OBX|367|TX| Biomarker Testing/Results: Not performed: test OBX|368|TX| OBX|369|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|370|TX|---------- End of Synoptic Report ---------- OBX|371|TX|-------- Ureter Renal Pelvis - Biopsy, 10 -------- OBX|372|TX| OBX|373|TX|SPECIMEN OBX|374|TX| Specimen: Renal pelvis OBX|375|TX| Specimen Laterality: Right OBX|376|TX| OBX|377|TX|TUMOUR OBX|378|TX| Tumour Configuration: Flat OBX|379|TX| Histologic Type: Urothelial carcinoma, invasive OBX|380|TX| Histologic Grade: High-grade OBX|381|TX| Tumour Extension: Tumour invades the muscularis OBX|382|TX| OBX|383|TX|ANCILLARY STUDIES OBX|384|TX| Best Tumour Block(s): test OBX|385|TX| Biomarker Testing/Results: Performed previously: test OBX|386|TX| OBX|387|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|388|TX|---------- End of Synoptic Report ---------- OBX|389|TX|-------- Colon and Rectum - Resection, 11 -------- OBX|390|TX| OBX|391|TX|SPECIMEN COMMENT OBX|392|TX| Pertains To: testing v.7.0.0.20 OBX|393|TX| OBX|394|TX|SPECIMEN OBX|395|TX| Procedure: Right hemicolectomy OBX|396|TX| Macroscopic Tumour Perforation: Present OBX|397|TX| OBX|398|TX|TUMOUR OBX|399|TX| Tumour Site: Cecum OBX|400|TX| Histologic Type: Adenocarcinoma OBX|401|TX| Histologic Grade: G1: Well differentiated (Low grade) OBX|402|TX| Tumour Size: 4 Centimeters (cm) OBX|403|TX| Tumour Extension: Tumour invades through the muscularis OBX|404|TX| propria into pericolorectal tissue OBX|405|TX| Lymphovascular Invasion: Present OBX|406|TX| Perineural Invasion: Present OBX|407|TX| OBX|408|TX|MARGINS OBX|409|TX| Proximal Margin: Cannot be assessed OBX|410|TX| Distal Margin: Cannot be assessed OBX|411|TX| Radial or Mesenteric Margin: Not applicable OBX|412|TX| OBX|413|TX|LYMPH NODES, REGIONAL OBX|414|TX| No lymph nodes present OBX|415|TX| OBX|416|TX|TREATMENT EFFECT OBX|417|TX| Single cells or rare small groups of cancer OBX|418|TX| cells (near complete response, score 1) OBX|419|TX| OBX|420|TX|PATHOLOGIC STAGE OBX|421|TX| pT3 pNX OBX|422|TX| OBX|423|TX|ANCILLARY STUDIES OBX|424|TX| Best Tumour Block(s): test OBX|425|TX| Biomarker Testing: Not performed: test OBX|426|TX| OBX|427|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|428|TX|---------- End of Synoptic Report ---------- OBX|429|TX|-------- GIST - Resection, 12 -------- OBX|430|TX| OBX|431|TX|SPECIMEN COMMENT OBX|432|TX| Pertains To: Testing v.7.0.0.5 OBX|433|TX| OBX|434|TX|SPECIMEN OBX|435|TX| Procedure: Resection OBX|436|TX| Type: test OBX|437|TX| OBX|438|TX|TUMOUR OBX|439|TX| Tumour Site: Colon OBX|440|TX| Tumour Size: 4 Centimeters (cm) OBX|441|TX| Tumour Focality: Unifocal OBX|442|TX| Histologic Type: GIST, spindle cell type OBX|443|TX| Histologic Grade: G2: High grade; mitotic rate > 5 / 5 mm2 OBX|444|TX| Mitotic Rate: 4 mitoses per 5 mm2 OBX|445|TX| Risk Assessment: Low risk OBX|446|TX| OBX|447|TX|MARGINS OBX|448|TX| Negative for GIST OBX|449|TX| Distance of Tumour from Closest OBX|450|TX| Margin: 3 Millimeters (mm) OBX|451|TX| OBX|452|TX|LYMPH NODES, REGIONAL OBX|453|TX| No lymph nodes present OBX|454|TX| OBX|455|TX|TREATMENT EFFECT OBX|456|TX| Preresection Treatment: Systemic therapy performed - test OBX|457|TX| Treatment Effect: Present OBX|458|TX| OBX|459|TX|PATHOLOGIC STAGE OBX|460|TX| pT2 pN0 OBX|461|TX| OBX|462|TX|ANCILLARY STUDIES OBX|463|TX| Best Tumour Block(s): test OBX|464|TX| Biomarker Testing / Results: Performed, see separate report: test OBX|465|TX| OBX|466|TX| OBX|467|TX| OBX|468|TX| Risk Assessment reference: 1 Miettinen M, OBX|469|TX| Lasota J. Gastrointestinal stromal tumors: OBX|470|TX| pathology and prognosis at different sites. OBX|471|TX| Semin Diagn Pathol. 2006;23(2):70-83. OBX|472|TX| OBX|473|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|474|TX|---------- End of Synoptic Report ---------- OBX|475|TX|-------- Ureter Renal Pelvis - Biopsy, 13 -------- OBX|476|TX| OBX|477|TX|SPECIMEN COMMENT OBX|478|TX| Pertains To: testing v.7.0.0.4 OBX|479|TX| OBX|480|TX|SPECIMEN OBX|481|TX| Specimen: Ureter OBX|482|TX| OBX|483|TX|TUMOUR OBX|484|TX| Tumour Configuration: Papillary OBX|485|TX| Histologic Type: Urothelial carcinoma, invasive OBX|486|TX| Histologic Grade: High-grade OBX|487|TX| Tumour Extension: Tumour invades subepithelial connective OBX|488|TX| tissue OBX|489|TX| OBX|490|TX|ANCILLARY STUDIES OBX|491|TX| Best Tumour Block(s): test OBX|492|TX| Biomarker Testing/Results: Performed, see separate report: test OBX|493|TX| OBX|494|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|495|TX|---------- End of Synoptic Report ---------- OBX|496|TX|-------- Colon and Rectum Excisional Biopsy (Polypectomy), 14 -------- OBX|497|TX| OBX|498|TX|SPECIMEN COMMENT OBX|499|TX| Pertains To: testing OBX|500|TX| OBX|501|TX|TUMOUR OBX|502|TX| Tumour Site: Cecum OBX|503|TX| Histologic Type: Adenocarcinoma OBX|504|TX| Histologic Grade: G1: Well differentiated (Low grade) OBX|505|TX| Tumour Extension: Tumour invades submucosa OBX|506|TX| Lymphovascular Invasion: Present OBX|507|TX| OBX|508|TX|MARGINS OBX|509|TX| Deep Margin: Negative for invasive carcinoma OBX|510|TX| Distance of Invasive Carcinoma OBX|511|TX| from Margin: 4 Millimeters (mm) OBX|512|TX| Mucosal Margin: Negative for invasive carcinoma OBX|513|TX| OBX|514|TX|PATHOLOGIC STAGE OBX|515|TX| pT1 OBX|516|TX| OBX|517|TX|ANCILLARY STUDIES OBX|518|TX| Best Tumour Block(s): test OBX|519|TX| Biomarker Testing: Not performed: test OBX|520|TX| OBX|521|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|522|TX|---------- End of Synoptic Report ---------- OBX|523|TX|-------- Adrenal - Biopsy; Resection, 15 -------- OBX|524|TX| OBX|525|TX|SPECIMEN COMMENT OBX|526|TX| Pertains To: testing v.7.0.0.6 OBX|527|TX| OBX|528|TX|SPECIMEN OBX|529|TX| Procedure: Adrenalectomy, total OBX|530|TX| Specimen Laterality: Bilateral OBX|531|TX| OBX|532|TX|TUMOUR OBX|533|TX| Tumour Size: 4 Centimeters (cm) OBX|534|TX| Weight: 3 g OBX|535|TX| Histologic Type: Adrenal cortical carcinoma, oncocytic type OBX|536|TX| Histologic Grade: High grade OBX|537|TX| Tumour Extension: Tumour invades into or through the adrenal OBX|538|TX| capsule OBX|539|TX| Lymphovascular Invasion: Large vessel invasion, not otherwise OBX|540|TX| specified; Microscopic angioinvasion OBX|541|TX| Tumour Description: Necrotic OBX|542|TX| OBX|543|TX|MARGINS OBX|544|TX| Negative for tumour OBX|545|TX| Margin: test OBX|546|TX| OBX|547|TX|LYMPH NODES, REGIONAL OBX|548|TX| No lymph nodes present OBX|549|TX| OBX|550|TX|PATHOLOGIC STAGE OBX|551|TX| mpT1 pNX OBX|552|TX| OBX|553|TX|ANCILLARY STUDIES OBX|554|TX| Best Tumour Block(s): test OBX|555|TX| Ancillary Studies: Ki-67 labeling index - 4%, Reticulin stain - OBX|556|TX| test, test OBX|557|TX| OBX|558|TX|COMMENTS OBX|559|TX| test OBX|560|TX| OBX|561|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC February 2019 OBX|562|TX|---------- End of Synoptic Report ---------- OBX|563|TX|-------- Prostate - Needle Biopsy Summary, 16 -------- OBX|564|TX| OBX|565|TX|SPECIMEN COMMENT OBX|566|TX| Pertains To: testing v.2.0.0.27 OBX|567|TX| OBX|568|TX|TUMOUR OBX|569|TX| Histologic Type: Adenocarcinoma (acinar) OBX|570|TX| Histologic Grade OBX|571|TX| Grade Group and Gleason Score: Grade group 3 (Gleason Score 4 + 3 = 7) OBX|572|TX| Percentage of Pattern 4: 60% OBX|573|TX| Lymph-Vascular Invasion: Present OBX|574|TX| Total Number of Cores: 6 OBX|575|TX| Number of Positive Cores: 1 OBX|576|TX| Number of Cores Positive on Left OBX|577|TX| Side: 1 OBX|578|TX| Number of Cores Positive on Right OBX|579|TX| Side: 0 OBX|580|TX| Total Linear Span of Carcinoma in OBX|581|TX| Cores: 5 mm OBX|582|TX| Total Length of Positive Needle OBX|583|TX| Cores: 10 mm OBX|584|TX| Proportion of Positive Cores OBX|585|TX| Involved by Tumour: 50 % OBX|586|TX| Periprostatic Fat Invasion: Present OBX|587|TX| Seminal Vesicle Invasion: Present OBX|588|TX| OBX|589|TX|Based on AJCC/UICC TNM, 7th edition OBX|590|TX|---------- End of Synoptic Report ---------- OBX|591|TX|-------- Prostate - Radical Prostatectomy, 17 -------- OBX|592|TX| OBX|593|TX|SPECIMEN COMMENT OBX|594|TX| Pertains To: testing v.7.0.0.16 OBX|595|TX| OBX|596|TX|SPECIMEN OBX|597|TX| Procedure: Radical prostatectomy OBX|598|TX| OBX|599|TX|TUMOUR OBX|600|TX| Histologic Type: Acinar adenocarcinoma OBX|601|TX| Histologic Grade OBX|602|TX| Grade Group and Gleason Score: Grade group 5 (Gleason Score 5 + 4 = 9) OBX|603|TX| Tertiary Gleason Pattern: Grade 3 OBX|604|TX| Percentage of Pattern 4: 25 % OBX|605|TX| Percentage of Pattern 5: 50 % OBX|606|TX| Extraprostatic Extension (EPE): Not identified OBX|607|TX| Urinary Bladder Neck Invasion: Not identified OBX|608|TX| Seminal Vesicle Invasion: Present OBX|609|TX| Treatment Effect: No known presurgical therapy OBX|610|TX| OBX|611|TX|MARGINS OBX|612|TX| Negative for invasive carcinoma OBX|613|TX| OBX|614|TX|LYMPH NODES, REGIONAL OBX|615|TX| No lymph nodes present OBX|616|TX| OBX|617|TX|PATHOLOGIC STAGE OBX|618|TX| pT3b pNX OBX|619|TX| OBX|620|TX|ANCILLARY STUDIES OBX|621|TX| Best Tumour Block(s): test OBX|622|TX| OBX|623|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|624|TX|---------- End of Synoptic Report ---------- OBX|625|TX|-------- Prostate - Radical Prostatectomy, 18 -------- OBX|626|TX| OBX|627|TX|SPECIMEN COMMENT OBX|628|TX| Pertains To: testing v.7.0.0.17 OBX|629|TX| OBX|630|TX|SPECIMEN OBX|631|TX| Procedure: Radical prostatectomy OBX|632|TX| OBX|633|TX|TUMOUR OBX|634|TX| Histologic Type: Acinar adenocarcinoma OBX|635|TX| Histologic Grade OBX|636|TX| Grade Group and Gleason Score: Grade group 4 (Gleason Score 5 + 3 = 8) OBX|637|TX| Tertiary Gleason Pattern: Grade 4 OBX|638|TX| Percentage of Pattern 4: 25 % OBX|639|TX| Percentage of Pattern 5: 50 % OBX|640|TX| Extraprostatic Extension (EPE): Present, focal OBX|641|TX| Urinary Bladder Neck Invasion: Not identified OBX|642|TX| Seminal Vesicle Invasion: Not identified OBX|643|TX| Treatment Effect: Not identified OBX|644|TX| OBX|645|TX|MARGINS OBX|646|TX| Negative for invasive carcinoma OBX|647|TX| OBX|648|TX|LYMPH NODES, REGIONAL OBX|649|TX| No lymph nodes present OBX|650|TX| OBX|651|TX|PATHOLOGIC STAGE OBX|652|TX| pT3a pNX OBX|653|TX| OBX|654|TX|ANCILLARY STUDIES OBX|655|TX| Best Tumour Block(s): test OBX|656|TX| OBX|657|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC February 2019 OBX|658|TX|---------- End of Synoptic Report ---------- OBX|659|TX|-------- Prostate - TUR; Enucleation Specimen, 19 -------- OBX|660|TX| OBX|661|TX|SPECIMEN COMMENT OBX|662|TX| Pertains To: testing v.7.0.0.6 OBX|663|TX| OBX|664|TX|SPECIMEN OBX|665|TX| Procedure: Enucleation OBX|666|TX| OBX|667|TX|TUMOUR OBX|668|TX| Histologic Type: Ductal adenocarcinoma OBX|669|TX| Histologic Grade OBX|670|TX| Grade Group and Gleason Score: Grade group 5 (Gleason Score 5 + 5 = 10) OBX|671|TX| Percentage of Pattern 5: 100% OBX|672|TX| Estimated Percentage of Prostatic OBX|673|TX| Tissue Involved by Tumour: 25% OBX|674|TX| Periprostatic Fat Invasion: Present OBX|675|TX| OBX|676|TX|ANCILLARY STUDIES OBX|677|TX| Best Tumour Block(s): test OBX|678|TX| OBX|679|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC February 2019 OBX|680|TX|---------- End of Synoptic Report ---------- OBX|681|TX|-------- Testis - Orchiectomy, 20 -------- OBX|682|TX| OBX|683|TX|SPECIMEN COMMENT OBX|684|TX| Pertains To: testing v.7.0.0.8 OBX|685|TX| OBX|686|TX|SPECIMEN OBX|687|TX| Specimen Laterality: Not specified OBX|688|TX| OBX|689|TX|TUMOUR OBX|690|TX| Histologic Type: Sex cord-stromal tumour type, unclassified; OBX|691|TX| Mixed germ cell-sex cord stromal tumour, OBX|692|TX| gonadoblastoma OBX|693|TX| Histologic Type Comments: test OBX|694|TX| Tumour Focality: Unifocal OBX|695|TX| Tumour Size: 4 Centimeters (cm) OBX|696|TX| Tumour Extension: Tumour invades hilar soft tissue OBX|697|TX| Lymphovascular Invasion: Present OBX|698|TX| OBX|699|TX|MARGINS OBX|700|TX| Spermatic Cord Margin: Negative for tumour OBX|701|TX| Other Margin(s): Negative for tumour OBX|702|TX| Margin(s): test OBX|703|TX| OBX|704|TX|LYMPH NODES, REGIONAL OBX|705|TX| No lymph nodes present OBX|706|TX| OBX|707|TX|PATHOLOGIC STAGE OBX|708|TX| pT2 pNX OBX|709|TX| OBX|710|TX|ANCILLARY STUDIES OBX|711|TX| Best Tumour Block(s): test OBX|712|TX| OBX|713|TX|ADDITIONAL FINDINGS OBX|714|TX| Microlith OBX|715|TX| OBX|716|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC February 2019 OBX|717|TX|---------- End of Synoptic Report ---------- OBX|718|TX|-------- Urinary Bladder - Biopsy; TURBT, 21 -------- OBX|719|TX| OBX|720|TX|SPECIMEN COMMENT OBX|721|TX| Pertains To: testing v.7.0.0.4 OBX|722|TX| OBX|723|TX|SPECIMEN OBX|724|TX| Procedure: Transurethral resection of bladder (TURBT) OBX|725|TX| OBX|726|TX|TUMOUR OBX|727|TX| Tumour Site: Dome OBX|728|TX| Histologic Type: Urothelial carcinoma, invasive OBX|729|TX| Histologic Grade: G1: Well differentiated OBX|730|TX| Muscularis Propria Presence: Muscularis propria (detrusor muscle) present OBX|731|TX| Tumour Extension: Urothelial carcinoma involving prostatic OBX|732|TX| urethra in prostatic chips sampled by TURBT OBX|733|TX| Lymphovascular Invasion: Present OBX|734|TX| OBX|735|TX|ANCILLARY STUDIES OBX|736|TX| Best Tumour Block(s): test OBX|737|TX| OBX|738|TX|ADDITIONAL PATHOLOGIC FINDINGS OBX|739|TX| Urothelial dysplasia OBX|740|TX| OBX|741|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC February 2019 OBX|742|TX|---------- End of Synoptic Report ---------- OBX|743|TX|-------- Urinary Bladder - Cystectomy, 22 -------- OBX|744|TX| OBX|745|TX|SPECIMEN COMMENT OBX|746|TX| Pertains To: testing v.7.0.0.7 OBX|747|TX| OBX|748|TX|SPECIMEN OBX|749|TX| Procedure: Radical cystectomy (total cystectomy) OBX|750|TX| OBX|751|TX|TUMOUR OBX|752|TX| Tumour Site: Dome OBX|753|TX| Histologic Type: Urothelial carcinoma invasive OBX|754|TX| Histologic Grade: G2: Moderately differentiated OBX|755|TX| Tumour Size: 4 Centimeters (cm) OBX|756|TX| Tumour Extension: Tumour invades perivesical tissue OBX|757|TX| Extent of Perivesical Invasion: Microscopically OBX|758|TX| Tumour Configuration: Ulcerated OBX|759|TX| Lymphovascular Invasion: Present OBX|760|TX| OBX|761|TX|MARGINS OBX|762|TX| Negative for invasive carcinoma and OBX|763|TX| carcinoma in situ / noninvasive urothelial OBX|764|TX| carcinoma OBX|765|TX| OBX|766|TX|LYMPH NODES, REGIONAL OBX|767|TX| No lymph nodes present OBX|768|TX| OBX|769|TX|PATHOLOGIC STAGE OBX|770|TX| pT3a pNX OBX|771|TX| OBX|772|TX|ANCILLARY TESTING OBX|773|TX| Best Tumour Block(s): test OBX|774|TX| OBX|775|TX|ADDITIONAL PATHOLOGIC FINDINGS OBX|776|TX| Urothelial dysplasia OBX|777|TX| OBX|778|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC February 2019 OBX|779|TX|---------- End of Synoptic Report ---------- OBX|780|TX|-------- Breast Biomarkers, 23 -------- OBX|781|TX| OBX|782|TX|SPECIMEN OBX|783|TX| Submitting Hospital Case Number: ; Block OBX|784|TX| Tested: test OBX|785|TX| OBX|786|TX|BREAST BIOMARKER TESTS OBX|787|TX| Ki-67: Low (Less than 10%) OBX|788|TX| OBX|789|TX|---------- End of Synoptic Report ---------- OBX|790|TX| OBX|791|TX|SPECIMEN SUBMITTED OBX|792|TX|TURB OBX|793|TX| ____________________________________ OBX|794|TX| Brigette Rabel OBX|795|TX| Electronically signed: 28/Nov/2019 OBX|796|TX| OBX|797|TX|-------------------------------------------------------------------------------------------- OBX|798|TX| OBX|799|TX| OBX|800|TX| OBX|801|TX| OBX|802|TX| OBX|803|TX| OBX|804|TX| OBX|805|TX| OBX|806|TX| OBX|807|TX| OBX|808|TX| OBX|809|TX|